Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-03-11 @ 1:02 AM
Study NCT ID:
NCT02152605
Status:
COMPLETED
Last Update Posted:
2017-11-09
First Post:
2014-05-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-01
Start Date Type:
None
Primary Completion Date:
2015-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03-05
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-29
First Submit QC Date:
None
Study First Post Date:
2014-06-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-19
Results First Submit QC Date:
None
Results First Post Date:
2016-02-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-09
Last Update Post Date:
2017-11-09
Last Update Post Date Type:
ACTUAL